Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Epilepsy Research|January 7, 2004
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEttore Beghi, Giuliana Gatti, Clara Tonini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2023
PRRT2 benign familial infantile seizures (BFIS) with atypical evolution to encephalopathy related to status epilepticus during sleep (ESES)Alberto Cossu, Joana L Santos, Giulia Galati, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatmentAllan Bayat, Stefano Iavarone, Francesco Miceli, et al.
Neuropediatrics|March 3, 2015
Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiencesAnna Biró, Ulrich Stephani, Tiziana Tarallo, et al.
Epilepsia|June 2, 2026
Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variantsCathrine E Gjerulfsen, Vivian W Y Liao, Tomasz S Mieszczanek, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Brain and Behavior|October 1, 2016
Review of clinical studies of perampanel in adolescent patientsHeung Dong Kim, Ching-Shiang Chi, Tayard Desudchit, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
American Journal of Human Genetics|April 14, 2015
Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic SeizuresGemma L Carvill, Jacinta M McMahon, Amy Schneider, et al.
Epilepsia|November 6, 2015
The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndromeJan Larsen, Katrine Marie Johannesen, Jakob Ek, et al.
Pageof 4